يحاول ذهب - حر
Navigating the Complexities of Pharma Packaging Sustainability
September 2025
|Bio Spectrum
Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.
There has been a paradigm shift towards sustainability, digitalisation and patient-focused solutions. Companies are transitioning to bioplastics, paper-based, and wood-based bio-PET alternatives, reducing reliance on petroleum-based plastics and lowering carbon footprints.
The pharma packaging industry is seeing a strong shift towards more patient-friendly packaging. Child-resistant designs are becoming a more commonly used feature in Over-The-Counter (OTC) products. The industry is also rapidly shifting towards opting for more sustainable manufacturing practices. Pharma manufacturers are not just working to reduce their carbon footprint, but are also choosing partners who can help them reduce their scope 3 emissions. The industry is seeing increased investments in packaging materials that are recyclable, reusable and bio-degradable. Medicines are travelling across continents facing diverse environmental conditions. This has amplified the need for robust, reliable packaging that can withstand varying temperatures, humidity, and handling challenges without compromising product integrity.
Innovations and initiatives
Pharma packaging is seeing major innovations. Usage of QR codes, Data Matrix codes and RFID (Radio Frequency Identification) tags provide instant access to comprehensive drug information (dosage, side effects, refill options). These enable real-time tracking throughout the supply chain. These also help in verifying authenticity and combating the growing problem of counterfeit medications.
The sector is witnessing a shift from static to dynamic packaging which includes AR, QR codes, personalised dosing, refillable designs and eco-friendly materials. Secondary packaging enhancements include blister packs, senior-friendly PFS kits, RFID/NFC labelling, easy-open blister seals etc.
هذه القصة من طبعة September 2025 من Bio Spectrum.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Bio Spectrum
Bio Spectrum
Thermo Fisher Scientific invests Rs 160 Cr+ to expand Bengaluru R&D facility
Thermo Fisher Scientific's expanded Research and Development (R&D) Centre of Excellence was inaugurated in Bengaluru by Sanjeev Kumar Gupta, CEO, Karnataka Digital Economy Mission (KDEM).
1 min
December 2025
Bio Spectrum
Motorica strengthens India presence with appointment of Kavinder Beniwal as COO
Motorica, a Delhi-based medtech company specialising in assistive technologies and medical cybernetics, has announced the appointment of Kavinder Beniwal as Chief Operational Officer (COO) of Motorica India.
1 min
December 2025
Bio Spectrum
Cabinet approves major expansion of PG and UG medical education capacity
Union Cabinet chaired by the Prime Minister Narendra Modi has approved the Phase-Ill of the Centrally Sponsored Scheme (CSS) for strengthening and upgradation of existing State Government/ Central Government Medical Colleges/Standalone PG Institutes/ Government Hospitals for increasing 5,000 PG seats and extension of the CSS for upgradation of existing government medical colleges for increasing 5,023 MBBS seats with an enhanced cost ceiling of Rs 1.5 crore per seat.
1 min
December 2025
Bio Spectrum
Dr Sharvil Patel steps in as Indian Pharmaceutical Alliance President
The Indian Pharmaceutical Alliance (IPA) has announced a leadership transition, with Dr Sharvil Patel, Managing Director of Zydus Lifesciences and former Vice President of IPA, assuming the role of President.
1 min
December 2025
Bio Spectrum
PAG-led Sekhmet Pharmaventures announces appointment of Mukesh Agarwal as CFO
Hyderabad-based Sekhmet Pharmaventures, a fast-emerging global API/CDMO player led by leading Asia-focused investment firm PAG, has announced the appointment of Mukesh Agarwal as its new Chief Financial Officer (CFO).
1 min
December 2025
Bio Spectrum
Monash University Malaysia and Tata Chemicals forge healthcare researchfocused partnership
The importance of gastrointestinal health is a key focus for researchers and innovators, as highlighted by the partnership between Monash University Malaysia and Tata Chemicals Limited.
1 min
December 2025
Bio Spectrum
"India has the talent and ambition to lead globally in advanced therapies, biologics, and oncology"
Thermo Fisher Scientific has recently announced plans to make significant investments in India's biopharma infrastructure, with new facilities that will enhance the biopharma manufacturing capabilities. Central to this expansion strategy are two major facilities in Genome Valley, Hyderabad, i.e. Bioprocess Design Center (BDC), and Customer Experience Center (CEC). In addition, the company has invested more than Rs 160 crore this year to expand its R&D facility in Bengaluru. For further understanding on these new developments, BioSpectrum spoke in detail to Srinath Venkatesh, Managing Director, India & South Asia, Thermo Fisher Scientific. Edited excerpts;
4 mins
December 2025
Bio Spectrum
"AI is a transformative enabler that's reshaping how science is conducted in labs"
2025 witnessed multiple new initiatives taken by Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, for the Indian market. These initiatives included establishment of an India Solutions Center in Manesar; and a Biopharma Experience Center in Hyderabad. 2025 also saw Nandakumar Kalathil stepping in as the new Country General Manager for Agilent India. With over 25 years of experience in the analytical industry, Nanda brings extensive expertise in leadership, team management, and customer relations. To find out more about the company's growth plans in 2026 in India, BioSpectrum interacted with Nandakumar Kalathil, Country General Manager for Agilent India in detail. Edited excerpts:
4 mins
December 2025
Bio Spectrum
Supporting India's Biopharma Expansion with Advanced, High-Performance Media
Kent Wang graduated from East China University of Science and Technology in Biochemical Engineering. He has over 12 years of experience in upstream biopharmaceutical process development, contributing to clinical projects including monoclonal antibodies, bispecific antibodies, and ADCs. He is well-versed in CHO cell metabolism and culture media characteristics, and has optimized critical quality attributes such as glycosylation, charge variants, fragmentation, aggregation, and amino acid oxidation. Previously at Shanghai Pharmaceuticals Group and 3S Bio, he now serves as Senior R&D Director at Duoning Biotech, focusing on serum-free cell culture media development. He established a comprehensive platform for media formulation and product development, leading his team to create a diverse portfolio of media for CHO, HEK293, insect, vaccine, hybridoma, and lymphocyte cell lines, leveraging cell metabolism insights and big data modeling.
4 mins
December 2025
Bio Spectrum
BTS 2025 Solidifies Karnataka's Global Tech Leadership
The 28th edition of the Bengaluru Tech Summit (BTS) 2025 concluded on November 20 at the Bangalore International Exhibition Centre (BIEC), wrapping up three days of high-impact innovation, global collaboration, and technology leadership.
3 mins
December 2025
Listen
Translate
Change font size

